* Neuronetics Inc is expected to show a rise in quarterly revenue when it reports results on November 12 for the period ending September 30 2024
* The Malvern Pennsylvania-based company is expected to report a 7.0% increase in revenue to $19.133 million from $17.88 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.The company's guidance on August 12 2024, for the period ended September 30, was for revenue between $18.50 million and $19.50 million.
* LSEG's mean analyst estimate for Neuronetics Inc is for a loss of 23 cents per share.
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the last three months.
* Wall Street's median 12-month price target for Neuronetics Inc is $3.00, above its last closing price of $1.08.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jun. 30 2024 -0.27 -0.27 -0.33 Missed -22.2
Mar. 31 2024 -0.32 -0.31 -0.27 Beat 12.9
Dec. 31 2023 -0.26 -0.26 -0.19 Beat 27.3
Sep. 30 2023 -0.31 -0.31 -0.33 Missed -6.7
Jun. -0.35 -0.35 -0.17 Beat 51.2
30 2023
Mar. 31 2023 -0.39 -0.39 -0.38 Beat 2.1
Dec. 31 2022 -0.35 -0.38 -0.30 Beat 21.3
Sep. 30 2022 -0.42 -0.42 -0.28 Beat 33.5
This summary was machine generated November 8 at 15:31 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。